GRAIL (GRAL) Is Up 21.5% After Samsung Partnership to Expand Galleri Test in Asia - What's Changed

By Yahoo! Finance | 1 month ago

Samsung C&T and Samsung Electronics invested $110 million in GRAIL for the Galleri multi-cancer test's commercialization in Asian markets, starting in South Korea and expanding to Japan and Singapore.

Did you find this insightful?